TMDX: The Medical Technology Stocks That Changed the Future

TransMedics Group (TMDX) is a medical technology company from the United States that developed Organ Care System (OCS), an organ preserver (heart, lung, liver) before transplantation. This technology prolongs the organ to remain intact, increasing patient survival chances.

If DCA is 5,000 baht per month for 10 years

Total investment ~ 600,000 baht

If you grow an average of 15% / year →, it can become 1.6-1.8 million.

If the average growth is 8% / year →, it may be around 8-9 lakh baht.

And if the market is bad → the principal may hardly grow.

Here's a reality investors need to understand: Stocks have both opportunities and risks.

Strengths of TMDX

✅ OCS technology doesn't have a direct competitor yet.

✅ The organ transplant market is in high demand worldwide.

✅ ROE ~ 28%, Net Margin ~ 13%, the company has profit potential.

Caution

⚠️ The stock swung 2 times stronger than the market.

⚠️ The stock value is quite expensive (P / E ~ 60x).

⚠️, no dividends and legal risks.

So TMDX fits the Growth / Healthcare Innovation portfolio down to a small proportion of 5-10% of the portfolio, not all stocks that should be put in money.

But what's more important than numbers is time.

Because if we do not invest at all, let alone diminish our work power, we run out of time. Every minute is precious. Even if our lives move forward, our time begins to count down every second.

The real risk is not to invest, but to do nothing.

Investment is not just "choice," it is "survival."

Stop saying risk and start studying, doing and giving money to work today. ✨

.

💡 If your friends like this post and want financial knowledge, investment,

Click Follow Page Capital Think 📌 We have DCA techniques, off-stream stocks and time ideas every week.

⬇️

/

# Capital think # Investment # Outside stock # Long investment # DCA